Bill would increase penalty on EpiPen manufacturers for flouting Colorado’s price cap

Denver Post

Center

High Factuality

Private Equity: Alden Global Capital

Bill would increase penalty on EpiPen manufacturers for flouting Colorado’s price cap

A bill in the Colorado legislature would allow stiffer penalties for EpiPen and insulin manufacturers who refuse to sell their products under the state’s price caps, which one generic drugmaker is challenging in court.